AD 923

· Sosei Group Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD 923, covering 2008-06-06 to 2008-06-06. Get the full timeline:

Most recent: Clinical Trial Update: A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects [Phase 3]

See pricing